ReviewSub-cellular biochemistry2025
Tissue Distribution, Expression and Regulation of Urea Transporters.
Review in Sub-cellular biochemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Urea Transporters in Cancer: Emerging Roles and Their Clinical Implications.Biomedicines · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
UT-A and UT-B families of urea transporters consist of multiple isoforms with the majority of the isoforms located in the kidney. UT-B (Slc14A1) in kidney is primarily located in the descending vasa recta. The UT-A (Slc14A2) urea transporter family comprises six distinct isoforms, three of which are predominantly found in the kidney. Specifically, UT-A1 and UT-A3 are located in the inner medullary collecting duct (IMCD), while UT-A2 is situated in the thin descending limb. These transporters play a crucial role in the renal concentration of urine. The regulation of renal urea transporter activity involves acute modifications through phosphorylation and subsequent translocation to the plasma membrane. In response to stimulation by vasopressin or hypertonicity, UT-A1 and UT-A3 accumulate in the IMCD plasma membrane. Chronic regulation of IMCD urea transporters involves hormonal modulation of protein expression levels, such as adrenal steroids, low-protein diets, electrolyte abnormalities, aging or other pathologic conditions. This chapter provides a brief overview of the tissue distribution, expression of the urea transporter isoforms, locations in the kidney, and regulation of urea transporters.
Indexed as
Identifiers
40637976What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.